Cargando…

Role of long non‐coding RNA in drug resistance in non‐small cell lung cancer

Lung cancer is the leading cause of cancer‐associated death, and non‐small cell lung cancer (NSCLC) accounts for 85% of all lung cancer cases. Many drugs have been used to treat NSCLC in order to improve patient prognosis. Platinum‐based chemotherapy is the first‐line treatment for locally advanced...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Leirong, Ma, Leina, Xu, Fei, Zhai, Wenxin, Dong, Shenghua, Yin, Ling, Liu, Jia, Yu, Zhuang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2018
Materias:	Mini Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026617/ https://www.ncbi.nlm.nih.gov/pubmed/29726094 http://dx.doi.org/10.1111/1759-7714.12652

Ejemplares similares

Blood cell parameters as prognostic predictors of disease development for patients with advanced non-small cell lung cancer
por: Wang, Leirong, et al.
Publicado: (2020)

Regulatory long non-coding RNA and its functions
por: Huang, Yong, et al.
Publicado: (2012)

Long non-coding RNAs during normal erythropoiesis
por: Xu, Changlu, et al.
Publicado: (2019)

The role and mechanism of long non-coding RNA H19 in stem cell osteogenic differentiation
por: Wang, Liang, et al.
Publicado: (2021)

Editorial focus: entering into the non-coding RNA era
por: Bartoszewski, Rafal, et al.
Publicado: (2018)

Analysis of the long non-coding RNA LINC01614 in non-small cell lung cancer
por: Sun, Yan, et al.
Publicado: (2019)

Long Non-Coding RNA in Drug Resistance of Non-Small Cell Lung Cancer: A Mini Review
por: Sun, Ruizheng, et al.
Publicado: (2019)

Sizing up long non-coding RNAs: Do lncRNAs have secondary and tertiary structure?
por: Novikova, Irina V., et al.
Publicado: (2012)

ARID1A serves as a receivable biomarker for the resistance to EGFR-TKIs in non-small cell lung cancer
por: Sun, Dantong, et al.
Publicado: (2021)

Long non-coding RNAs: key regulators of liver and kidney fibrogenesis
por: Han, Su-hyang, et al.
Publicado: (2023)

Common and distinct features of potentially predictive biomarkers in small cell lung carcinoma and large cell neuroendocrine carcinoma of the lung by systematic and integrated analysis
por: Dong, Shenghua, et al.
Publicado: (2020)

Recent advances in neoantigen vaccines for treating non‐small cell lung cancer
por: Su, Shu, et al.
Publicado: (2023)

Rationale for concurrent chemoradiotherapy for patients with stage III non-small-cell lung cancer
por: Conibear, John
Publicado: (2020)

Long Non-Coding RNA THOR Depletion Inhibits Human Non-Small Cell Lung Cancer Cell Growth
por: Jiao, Peng-Fei, et al.
Publicado: (2021)

KRAS oncogene may be another target conquered in non‐small cell lung cancer (NSCLC)
por: Chen, Hanxiao, et al.
Publicado: (2020)

Long Non-coding RNA DUXAP8 Regulates the Cell Proliferation and Invasion of Non-small-cell Lung Cancer
por: Yang, Si-Jia, et al.
Publicado: (2019)

Long non‐coding RNA linc01433 promotes migration and invasion in non‐small cell lung cancer
por: Qian, Banglun, et al.
Publicado: (2018)

Non-coding antisense transcripts: fine regulation of gene expression in cancer
por: Santos, Francisco, et al.
Publicado: (2022)

Long non-coding RNAs in non-small cell lung cancer: implications for EGFR-TKI resistance
por: Liu, Detian, et al.
Publicado: (2023)

Oncogene addiction and tumor mutational burden in non‐small‐cell lung cancer: Clinical significance and limitations
por: Smolle, Elisabeth, et al.
Publicado: (2019)

Long Non-coding RNA in Neuronal Development and Neurological Disorders
por: Li, Ling, et al.
Publicado: (2019)

Targeting the PI3K/Akt/mTOR pathway in non‐small cell lung cancer (NSCLC)
por: Tan, Aaron C.
Publicado: (2020)

Practical implications to contemplate when considering radical therapy for stage III non-small-cell lung cancer
por: Storey, Claire L., et al.
Publicado: (2020)

Expression and Effects of Long Non-Coding RNA, LINC01124, in Non-Small Cell Lung Cancer
por: Wang, Zi-Bo, et al.
Publicado: (2019)

Magnetic resonance imaging for N staging in non-small cell lung cancer: A systematic review and meta-analysis
por: Zhang, Yuanyuan, et al.
Publicado: (2015)

Immunotherapy in Cancer Management: A Literature Review of Clinical Efficacy of Pembrolizumab in the Non-small Cell Lung Cancer Treatment
por: Miquelotti, Luísa Biscaglia, et al.
Publicado: (2023)

Long Non-coding RNAs and Their Roles in Non-small-cell Lung Cancer
por: Wei, Ming-Ming, et al.
Publicado: (2016)

Long non-coding RNAs associated with non-small cell lung cancer
por: Zhan, Yuting, et al.
Publicado: (2017)

Long non-coding RNA FOXF1 adjacent non-coding developmental regulatory RNA inhibits growth and chemotherapy resistance in non-small cell lung cancer
por: Xu, Ran, et al.
Publicado: (2019)

The role of IL‐6 in immunotherapy of non‐small cell lung cancer (NSCLC) with immune‐related adverse events (irAEs)
por: Ke, Wanhai, et al.
Publicado: (2020)

Clinical significance of long non-coding RNA HOTTIP in early-stage non-small-cell lung cancer
por: Navarro, Alfons, et al.
Publicado: (2019)

Long non-coding RNA dysregulation is a frequent event in non-small cell lung carcinoma pathogenesis
por: Acha-Sagredo, Amelia, et al.
Publicado: (2020)

Long non-coding RNA NEAT1 regulates ferroptosis sensitivity in non-small-cell lung cancer
por: Wu, Hongxia, et al.
Publicado: (2021)

High expression of long non-coding RNA SBF2-AS1 promotes proliferation in non-small cell lung cancer
por: Lv, Junjie, et al.
Publicado: (2016)

18F‐fluorodeoxyglucose positron emission tomography/computed tomography in the evaluation of clinically node‐negative non‐small cell lung cancer
por: Takahashi, Yusuke, et al.
Publicado: (2019)

Postoperative radiotherapy for patients with completely resected stage IIIA‐N2 non‐small cell lung cancer: opt‐in or opt‐out
por: Zhu, Lucheng, et al.
Publicado: (2022)

Increased serum exosomal long non‐coding RNA SNHG15 expression predicts poor prognosis in non‐small cell lung cancer
por: Han, Pengfei, et al.
Publicado: (2021)

Long Non-coding RNA
por: Gullerova, Monika
Publicado: (2015)

Long non-coding RNA BZRAP1-AS1 functions in malignancy and prognosis for non-small-cell lung cancer
por: Hao, Xuefeng, et al.
Publicado: (2022)

Curative effect assessment of immunotherapy for non‐small cell lung cancer: The “blind area” of Immune Response Evaluation Criteria in Solid Tumors (iRECIST)
por: Song, Peng, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7g1scjqh279gcb1e5ocv77np1l